Struggling Avivagen exploring potential sale as part of strategic review – Ottawa Business Journal

Avivagen is reviewing “strategic alternatives” that could include selling the embattled Ottawa-based life sciences company as it struggles to gain market traction for its natural immune-boosting compound.

Related Keywords

Peru ,Ottawa ,Ontario ,Canada ,Australia ,Argentina ,China ,Colombia ,Uruguay ,Mexico ,United States ,Costa Rica ,Kym Anthony ,Venture Exchange ,Anthony ,Thursday The ,Uruguay The ,